A person-centred approach focussing on updated weight loss targetsnow achievable with therapies such as tirzepatidemay improve not only glycaemic control but also other metabolic complications for people with adiposity-associated T2D, including blood pressure, lipids, obstructive sleep apnoea and fatty liver disease
You know Mark Cuban
This balanced approach may contribute to its overall metabolic profile
Beginning with 3 mg daily for the first few days before increasing to 5 mg can help identify those who experience excessive drowsiness or circadian disruption from standard doses
If your BMI, according to this calculator, is lower than 35, which would be 204 pounds at 5 feet, 4 inches or 237 pounds at 5 feet, 9 inches, you must also have an attendant medical condition to qualify for the new benefit
Non-surgical weight loss programs are suitable for: people who are overweight or obese